observing national and local regulations
ImporteurinformationenName: Emergo EuropeAdresse: Westervoortsedijk 60
it is recommended that solutions containing quaternary ammonium compounds as biocidal preservatives be rinsed before injection
Do not administer if infections or skin diseases are present at the injection site
• Increasing injection pressure may indicate that the needle is incorrectly positioned outside the joint or that the joint is overfilled
Synolis VA 80/160 1x 4,0 ml 1328464 observing national and local regulationsInstructions for use SYNOLIS VA Description SYNOLIS VA is a viscoelastic, sterile, apyrogenic, isotonic, buffered 2% sodium hyaluronate solution. The sodium hyaluronate used in SYNOLIS VA is obtained by bacterial fermentation and has a high average molecular weight (MW) of 2 MDa. SYNOLIS VA has a neutral pH of 6. 87. 4, similar to synovial fluid. A high concentration and high molecular weight of sodium hyaluronate combined with a polyol (sorbitol),